a Randomised, Double Blind, Placebo Controlled, Half- Face Study to Evaluate the Effect of Topical Ivermectin Cream 0.5% on Demodicidosis

NCT02036229 Phase 3 UNKNOWN

The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the treatment of demodicidosis (including papulopustular rosacea)

Details

Lead sponsor	Rabin Medical Center
Phase	Phase 3
Status	UNKNOWN
Enrolment	50
Start date	2014-02
Completion	2016-06

Conditions

• Demodicidosis
• Rosacea

Interventions

• ivermectin cream 0.5%

Primary outcomes

• A decrease in mite density in skin surface biopsy after treatment with topical ivermectin (≤5 mites/cm2 for skin lesions). — 5 months

Countries

Israel